Middle East Pharmaceutical Company Ltd. (4016)
Tadawul
Closed
Aug 27, 2026
Day's Range
63.2052 wk Range
53.89Overview - 4016 - Middle East Pharmaceutical Company Ltd.
Key Statistics
Valuation
Enterprise Value
2.33B
P/E (Trailing)
‪21.87‬
P/E (Forward)
‪12.69‬
PEG Ratio
‪-1.03‬
Price / Sales (TTM)
‪4.42‬
Price / Book
‪5.08‬
EV / EBITDA
‪17.91‬
Profitability
Gross Margin
‪61.95%‬
Profit Margin
‪21.18%‬
Operating Margin
‪24.68%‬
Return on Assets
‪12.10%‬
Return on Equity
‪26.12%‬
Ownership
Shares Outstanding
35.00M
Float
16.40M
Held by Insiders
‪53.12%‬
Held by Institutions
‪0.51%‬
Price stats
Beta
‪0.45‬
50-Day Avg
‪60.52‬
200-Day Avg
‪61.48‬
Dividends
Payout Ratio
‪46.72%‬
Frequency
Semi-Annual
Analyst Consensus
1 analysts
Market Cap - 4016 - Middle East Pharmaceutical Company Ltd.
Peers - 4016 - Middle East Pharmaceutical Company Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Tadawul.
- 4016TadawulMiddle East Pharmaceutical Company Ltd.2.26BMarket Cap-12.26%52-week change21.88P/E (Trailing)‪21.18%‬Profit Margin
- 4015TadawulJamjoom Pharmaceuticals Factory9.72BMarket Cap-13.18%52-week change20.52P/E (Trailing)‪30.54%‬Profit Margin
- 2230TadawulSaudi Chemical Company Holding6.56BMarket Cap+14.51%52-week change18.55P/E (Trailing)‪4.99%‬Profit Margin
- 3030TadawulSaudi Cement Company4.43BMarket Cap-34.74%52-week change12.24P/E (Trailing)‪22.08%‬Profit Margin
- 2070TadawulSaudi Pharmaceutical Industries and Medical Appliances Corporation3.69BMarket Cap+15.97%52-week change17.28P/E (Trailing)‪12.33%‬Profit Margin
Profile Summary - 4016 - Middle East Pharmaceutical Company Ltd.
About
Middle East Pharmaceutical Company Ltd. is a prominent entity in the pharmaceuticals sector, primarily involved in the manufacture and distribution of a wide range of healthcare products. Focused on addressing local and regional healthcare needs, the company delivers medicinal products that serve therapeutic areas…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
